Figure 2From: Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines Anti-EGFR immunostaining pattern in HT-29 and Caco-2 cell lines, respectively. a, b (untreated); c, d (10 nM EGF treated); e, f (5 nmol/L cetuximab treated); g, h (5 nmol/L cetuximab plus 10 nM EGF treated).Back to article page